Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 2 1

Status

Completed 3Unknown 2Terminated 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2Other solid neoplasm 2Sarcoma 1Gynecologic 1Gastrointestinal 1

Conditions

Breast Neoplasms 31Lymphoma 18Lymphoma, Large B-Cell, Diffuse 17Sarcoma 13Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Neoplasm Metastasis 10Hodgkin Disease 9Lymphoma, Non-Hodgkin 8Recurrence 7Prostatic Neoplasms 7Neoplasms 7Multiple Myeloma 7Burkitt Lymphoma 7Ovarian Neoplasms 6Leukemia 6Lymphoma, B-Cell 5Fallopian Tube Neoplasms 5Cardiotoxicity 5Carcinoma, Hepatocellular 5Urinary Bladder Neoplasms 4Osteosarcoma 4Liver Neoplasms 4Triple Negative Breast Neoplasms 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Pancreatic Neoplasms 3Lymphoma, Follicular 3Leukemia, Myeloid, Acute 3Leukemia, Biphenotypic, Acute 3Colonic Neoplasms 3Waldenstrom Macroglobulinemia 2

Interventions

Pemetrexed 9Cisplatin 9pembrolizumab 5defactinib 3Cyclophosphamide 3sodium thiosulfate 2Radiotherapy, Intensity-Modulated 2Platinum 2Immunoenzyme Techniques 2Doxorubicin 21,2-diaminocyclohexaneplatinum II citrate 2vatalanib 1spartalizumab 1osimertinib 1nintedanib 1liposomal doxorubicin 1cabozantinib 1antineoplaston AS 2-1 1antineoplaston A10 1amatuximab 1alvocidib 1aldesleukin 1X-Rays 1VS-5584 1Trabectedin 1Tetrahydrouridine 1Specimen Handling 1Ramucirumab 1Radiotherapy 1Radiation Dose Hypofractionation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Mesothelioma, Malignant × Doxorubicin × Clear all
NCT04213794 2025-02-20

TOASTIT

Mayo Clinic

Phase EARLY_PHASE1 Terminated
2 enrolled
GastrointestinalGynecologicOther solid neoplasmSarcomaThoracic

Mesothelioma, Malignant, Colonic Neoplasms, Fallopian Tube Neoplasms, Liposarcoma, Ovarian Neoplasms, Pelvic Neoplasms, Rectal Neoplasms, Rhabdomyosarcoma, Sarcoma, Stomach Neoplasms, Desmoplastic Small Round Cell Tumor

NCT00859495 2020-08-25

Trimodal Lung-Sparing Treatment of Pleural Mesothelioma

Columbia University

Phase 2 Terminated
9 enrolled 4 charts
Other solid neoplasmThoracic

Mesothelioma, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡